[The clinical efficacy and safety of lenalidomide plus rituximab regimen in the treatment of elderly or relapsed/refractory B-non-Hodgkin's lymphoma patients]

Zhonghua Xue Ye Xue Za Zhi. 2017 Jul 14;38(7):634-636. doi: 10.3760/cma.j.issn.0253-2727.2017.07.018.

[Article in Chinese]

¹ Department of Hematopathy, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.

No abstract available

Grants and funding

基金项目：国家自然科学基金（81000921）；河南省自然科学基金（162300410280）